Income Statement
60 DEGREES PHARMACEUTICALS, INC.
SXTP
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Revenue
|
1.01 | 0.61 | 0.25 |
|
Cost of Revenue
|
0.78 | 0.38 | 0.47 |
|
Gross Profit
|
0.22 | 0.22 | -0.22 |
|
Operating Expenses
|
8.39 | 10.01 | 4.93 |
|
Research & Development
|
2.11 | 4.99 | 0.69 |
|
Selling, General & Administrative
|
6.28 | 5.02 | 4.24 |
|
Other Operating Expenses
|
- | - | - |
|
Operating Income
|
-8.16 | -9.79 | -5.15 |
|
Non-Operating Income
|
0.39 | -1.83 | -1.34 |
|
Interest Income
|
- | - | - |
|
Interest Expense
|
- | 0.00 | 2.29 |
|
Other Non-Op Income / Expense
|
0.13 | 0.10 | -0.08 |
|
Income Before Tax
|
-7.37 | -7.96 | -3.81 |
|
Income Tax Expense
|
0.00 | -0.01 | -0.05 |
|
Non-Controlling Interest
|
0.00 | -0.01 | -0.05 |
|
Net Income
|
-7.37 | -7.95 | -3.77 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - |
|
EBITDA
|
-8.16 | -9.79 | -5.15 |
|
Earnings Per Share (Basic)
|
-11.73 | -18.55 | -0.99 |
|
Diluted EPS
|
-11.73 | -18.55 | - |
|
Weighted Average Shares
|
0.67 | 0.45 | 3.96 |
|
Diluted Weighted Avg Shares
|
0.67 | 0.45 | - |
|
Comprehensive Income
|
-7.36 | -7.95 | -3.70 |